Al-Ola Abdallah/LinkedIn
Sep 7, 2025, 13:16
Al-Ola Abdallah: Great Session at the Multisplinacry PCD Monthly Meeting on Talquetmab in Active PCD
Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on LinkedIn:
“Had a great session at the Multisplinacry PCD monthly meeting (9/4)
By Ellen Ogbonna, Jordan Snyder myself
Guided by JK (Jeries Kort)
Topic: Talquetmab in Active PCD
• exploring its future use in AL Amyloidosis
Exciting insights and discussions ahead for patients and care.”
More from Al-Ola Abdallah on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 14:05
Sep 7, 2025, 13:10
Sep 7, 2025, 12:35
Sep 7, 2025, 12:14